Cardinal Health stock
Price history
+36.67% over the period1 year: from $206.18 (November 17, 2025) to $281.80 (November 17, 2026), +36.67%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $281.80 |
| October 30, 2026 | $250.48 |
| September 30, 2026 | $222.50 |
| August 31, 2026 | $234.62 |
| July 31, 2026 | $230.03 |
| June 30, 2026 | $237.56 |
| May 29, 2026 | $196.80 |
| April 30, 2026 | $192.88 |
| March 31, 2026 | $211.31 |
| February 27, 2026 | $229.23 |
| January 30, 2026 | $214.88 |
| December 31, 2025 | $205.50 |
| November 28, 2025 | $212.26 |
| November 17, 2025 | $206.18 |
At a glance
The company
Distributor of pharmaceutical, medical and surgical products and provider of healthcare supply chain solutions and services
Latest results
Quarter to September 30, 2026 · EPS $3.26 (estimate $2.95)
Next event
TickerLandia's take on Cardinal Health
- Pricier than usual relative to earnings: P/E on the latest fiscal year 39 vs a median of 28 over its last 8 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 36 vs 28 (+29%) in a group of 11.
- Strong point: Market momentum (90/100 in its group). Weak point: Profitability (15/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−2.46% from the 52-week high
Analysts · 17 analysts
Average target$294.87+5.59% vs. price
Buy 14 · Hold 3 · Sell 0 · Buy
TickerLandia Fingerprint: Cardinal Health
Compared with similar companies: very strong momentum and very low profitability.
Financials and price compared with 11 companies in the medical distribution industry, worldwide. Momentum and risk compared with 883 North American stocks.
Priceaverage57
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 36.4 77 Forward P/E 19.5 59 Price/sales 0.25 32 EV/EBITDA 15.6 59 Profitabilityvery low15
How much it earns on revenue and capital.
Metric Value Position in group ROE −63.6% 14 ROA 3.7% 41 Gross margin 3.9% 14 Net margin 0.7% 5 Operating margin 1.3% 5 Earnings stabilitylow23
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.6% 41 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 5 Growthaverage50
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +26.60% 65 Revenue growth (year over year) +5.50% 36 Average revenue growth (3 years) +7.44% 50 Financial strengthaverage58
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength · negative shareholders' equity −3.67 86 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.21 65 Interest coverage 9.45 68 Current ratio 0.89 14 Dividendaverage58
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 26.6% 45 Consecutive dividend years at least 37 years 95 Dividend yield 0.7% 35 Market momentumvery strong90
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +23.75% 94 Relative strength (6 months) +42.90% 93 1-year return +35.44% 78 Distance from 200-day average +23.70% 94 Risklow22
How much the price swings.
Metric Value Position in group Volatility (60 days) 23.9% 21 Beta (1 year) −0.01 16 Maximum drawdown (12 months) 20.6% 28
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Cardinal Health is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Cardinal Health's P/E today is 39.0, above the median of its last 8 fiscal years (28.0; between 10.4 and 75.1 from 2017 to 2026). Cardinal Health's P/E (trailing 12 months): 36.4, +29% against the median of a group of 11 similar companies (28.2).
Compared with 11 similar companies
| Metric | Cardinal Health | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 36.4 | High | |
| Forward P/E | 19.5 | Middle | |
| Operating margin | 1.3% | Low | |
| ROE | -63.6% | Low | |
| Debt/equity | -3.67 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Cardinal Health. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$63.67B
Latest quarter · Q2 2026
Net income
$398M
Latest quarter · Q2 2026
Quarterly net margin
0.6%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $64.97B
- P/E
- 36.4
- EPS
- $7.73
- Volume
- 1.25M
- Daily trading
- €402.46M
- Dividend yield
- 0.74%
- Last ex-dividend on October 1, 2026
How Cardinal Health is changing
All resultsRevenue grew 9.4% a year on average over the last 5 years
Shares outstanding down 19.4% in 5 years
Profitable in 4 of 5 fiscal years
Returns
Cardinal Health returns with dividends
$1,000 invested in Cardinal Health 5 years ago, on November 17, 2021, would be worth $6,273 today with dividends reinvested: +527.31% in total, +44.38% per year. On price alone it would be $5,666 (+466.65%).
| Period | Cardinal Health | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +11.54% | −3.17% | $1,115 |
| 6 months | +43.06% | +0.11% | $1,431 |
| Year to date | +37.13% | +8.34% | $1,371 |
| 1 year | +37.95% | +11.15% | $1,380 |
| 3 years | +184.45% | +64.30% | $2,845 |
| 5 years | +527.31% | +58.18% | $6,273 |
| 10 years | +417.69% | +239.10% | $5,177 |
Over the last 6 months it has done better than 83% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Cardinal Health: technical analysis
Cardinal Health is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 1.6% below its highest close since January 2, 1990 ($283.85, November 16, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 72
- Above 70: a strong rise in a short time
- vs 200-session average
- +23.70%
Active signals
RSI above 70: the stock has risen a lot in a short time.
since November 5, 2026
Support and resistance
Price areas where Cardinal Health has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$279.25
- Support$258.75−7.34%2 touches, last on October 22, 2026
- Support$243.35−12.86%2 touches, last on October 28, 2026
- Support$229.24−17.91%2 touches, last on August 24, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- −0.01
- Volatility (60 sessions, annualised)
- 23.9%
- Largest fall in the last year
- −20.61%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Cardinal Health: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Cardinal Health has been November: +3.89% on average, positive in 26 years out of 36. The weakest has been April: −0.78% on average, positive in 14 years out of 37.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +3.07% | +2.81% | 26 of 36 |
| February | +1.60% | +1.97% | 26 of 37 |
| March | +0.11% | −0.07% | 18 of 37 |
| April | −0.78% | −1.95% | 14 of 37 |
| May | +2.49% | +2.03% | 24 of 37 |
| June | +1.36% | 0.00% | 18 of 37 |
| July | +0.79% | +2.55% | 22 of 37 |
| August | +0.61% | +0.53% | 21 of 37 |
| September | +0.08% | −0.58% | 18 of 37 |
| October | +1.66% | +4.75% | 21 of 37 |
| November | +3.89% | +4.05% | 26 of 36 |
| December | +0.92% | +0.03% | 19 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Cardinal Health and its competitors
Customers of this US company include hospital and pharmacy operators, physicians, surgery centers, clinical laboratories and patients who receive care at home, and its activity is concentrated in the United States. Its operations are organized into two segments, one covering pharmaceuticals and specialty solutions and the other global medical products and distribution. It distributes branded, generic and over-the-counter pharmaceuticals, runs pharmacies, repackages generic drugs and supplies pharmaceutical manufacturers with services for specialty products.
- Headquarters
- Dublin, United States
- Employees
- 58,788
- Founded
- 1979
- Chief executive
- Jason Hollar
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Cardinal HealthCAH | $64.97B | 1.3% | 36.4 | +43.06% |
| CencoraCOR | $68.11B | 1.4% | 20.0 | +36.03% |
| McKessonMCK | $126.04B | 1.6% | 28.2 | +43.53% |
| Henry ScheinHSIC | $9.17B | 5.8% | 22.7 | +14.05% |
| Sigma HealthcareSIG | $22.55B | 9.2% | 48.3 | +3.55% |
| Sinopharm Group Ltd H1099 | $6.68B | 3.0% | 6.51 | −3.31% |
Same industry or related industries, similar size. Compare Cardinal Health with its competitors · Full profile
